IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A (IGA) NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A (IGA) NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A (IGA) NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to protect transplanted kidneys from damage
Disease control Recruiting nowThis study is testing whether a medication called sparsentan can safely reduce protein in the urine of kidney transplant patients whose original kidney disease has returned. About 20 adult participants who received a transplant at least one year ago will take the daily tablet for…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
First gene therapy tested for serious kidney disease
Disease control Recruiting nowThis is the first study in humans to test a new gene therapy called PS-002 for adults with IgA nephropathy, a serious kidney disease. The main goal is to see if the treatment is safe and well-tolerated, while also checking for early signs that it might help control the disease. T…
Matched conditions: IMMUNOGLOBULIN A (IGA) NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Purespring Therapeutics Limited • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC